Welcome
Dear reader,
On 19 November 2013, the 7th Netherlands Conference on HIV Pathogenesis, Epidemiology, Prevention and Treatment took place at the Royal Tropical Institute (KIT) in Amsterdam. In this newsletter we look back at the conference and include interviews with some of this year’s guest speakers including Javier Martinez-Picado, Rochelle Walensky and Jürgen Rockstroh. Each interview focuses on the subject they discussed in their presentation at the conference.
New this year is that we have recorded the presentations of the guest speakers, who granted permission to do so, as webcasts. I invite those who could not attend the conference and those who want to see one of the presentations once more to take a look at the webcasts available at the NCHIV website (www.nchiv.org). Finally, in this newsletter we discuss our yearly Monitoring Report which has recently been published.
I hope that you enjoy reading this newsletter.
With kind regards,
Peter Reiss
Directeur, Stichting HIV Monitoring
NCHIV 2013 highlights
19 November 2013, the 7th NCHIV Conference took place at the Royal Tropical Institute (KIT) in Amsterdam. This year’s edition consisted of a varied programme with contributions from four international speakers, complemented with five Dutch guest speakers and nine oral abstract presenters.
Also, this year’s conference included both an Opening and Closing Keynote presented by Javier Martinez-Picado and Rochelle Walensky. Interviews with both Keynote speakers are included in this newsletter. Additionally 37 posters were presented during the lunch break. Lastly, presentations from guest speakers were recorded as webcasts, which are now available through the NCHIV website.
» Go to the NCHIV website
» Download one of the presentations
» Watch one of the webcasts
HIV-vaccinations and cure - an interview with Prof. Martinez-Picado
As Keynote speaker during the NCHIV 2013 conference, Prof. Martinez-Picado discussed the path towards a cure for HIV and how a combination of existing techniques is most likely to create a functional cure for HIV. In this interview he elaborates on his research, the problems with vaccination for HIV and the best approach to finding a cure for HIV.
» Read the interview
» Download the NCHIV presentation (PDF) of Prof. Martinez-Picado
Cost-effectiveness of HIV treatment - an interview with Prof. Walensky
During her Keynote at NCHIV 2013 Prof. Walensky discussed cost-effectiveness analyses and their contribution to optimizing HIV-related treatment and policy decisions around the world. We interviewed Prof. Walensky on her work as researcher and her recent publication in the NEJM about cost-effectiveness analyses in resource-limited settings.
» Read the interview
» Watch the webcast of Prof. Walensky's NCHIV presentation
» Download the NCHIV presentation (PDF) of Prof. Walensky
Hepatitis C novel treatments; challenges and opportunities - an interview with Prof. Rockstroh
At NCHIV Prof. Jürgen Rockstroh presented on hepatitis C; novel and future treatment strategies. We interviewed Prof. Rockstroh on his work at the HIV treatment centre in Bonn and the research they do on hepatitis C. Furthermore he elaborates on the chances and challenges of new HCV medication.
» Read the interview
» Watch the webcast of Prof. Rockstroh's NCHIV presentation
» Download the NCHIV presentation (PDF) of Prof. Rockstroh
Monitoring Report 2013
The Monitoring Report 2013 has now been published and available through our website. A Dutch summary is also available through the website. An important conclusion of this year’s report is that there is a sustained increase in the number of HIV-infected patients in care in Dutch treatment centres.
Besides reporting on the HIV epidemic in the Netherlands, this year’s report also contains a section on hepatitis C co-infection. A press release about both subjects has been sent out and can also be found on our website.
» Read the press release on the sustained increase of HIV-patients
» Read the press release on hepatitis C as co-infection
» Download the full Monitoring Report 2013
» Download the Dutch Summary 2013
NCHIV posters, presentations and photo's now online
The posters and presentations that were presented during NCHIV are now available as download via the NCHIV website. Furthermore, all photo’s that were taken during the conference are available through the NCHIV website. Also, as mentioned earlier on in this newsletter, we have recorded the presentations of the guest speakers (who granted permission to do so) as webcasts. These webcasts are now available online via the NCHIV website.
» Go to the NCHIV website
Publicatie review
The Presence of CXCR4-Using HIV-1 Prior to Start of Antiretroviral Therapy Is an Independent Predictor of Delayed Viral Suppression.
Disease progression is accelerated in untreated patients with HIV variants that are using the CXCR4 coreceptor. After initiation of cART it also appears to take longer to achieve viral suppression. However, the reconstitution of the immune system is similar to that of patients without this HIV variant.
» Read the abstract
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study.
Also for HIV patients cancers are an important cause of mortality. For lung cancer and disseminated cancer the prognosis is worse than for other types of cancer. For modifiable risk factors, such as smoking and low CD4 counts, the same is also true.
» Read the abstract
Changes in First-Line cART Regimens and Short-Term Clinical Outcome between 1996 and 2010 in The Netherlands.
Changes in the use of first-line cART in the Netherlands between 1996 and 2010 closely follow changes in treatment guidelines. Because adherence has improved due to newer drugs with better tolerability, the immunologic and virologic response has improved.
» Read the abstract
Facts and figures
This year, the 7th NCHIV conference was visited by 290 doctors, researcher, HIV-nurses, pharmaceutical representatives, and other interested participants. 18 presentations were given in total and 37 posters on subjects varying from HIV prevention to treatment and cure were presented.
(c) Stichting HIV Monitoring, 2013 Privacy Policy
